Pharmaceutical giant Ranbaxy on Monday said that it has received tentative approval from the US Food and Drug Administration to manufacture and market carvedilol tablets for treatment of cardiac disorders including hypertension.\n\n\n\n
Kopran Ltd launched two new cardiovascular drugs - Caditone (Carvedilol) for the treatment of hypertension and congestive cardiac failure and Zeter (Clopidogrel) to prevent blockage of artery by clot formation (thrombosis).